Evozyne in the News

Biotech Veteran Marc Yoskowitz Named Evozyne CEO

Jan 4, 2024

NBC Chicago: Can artificial intelligence cut down on the time and cost it takes to save lives?

Nov 14, 2023

Evozyne Announces $81 Million Financing Round to Advance Generative AI for Therapeutic Discovery and Drug Development

Sep 27, 2023

The Science Behind Evozyne

Jun 27, 2023

Our Successful Collaboration with NVIDIA

Jun 15, 2023

Celebrating Our Three Year Anniversary

Jun 14, 2023

Evozyne Creates AI Model with NVIDIA for Novel Protein Design, Expected to Accelerate Drug Development

Jan 12, 2023

Veteran Technology Executive Mike Gamson Named Evozyne CEO

Jan 9, 2023

Evozyne Hires Chief Operating Officer to Scale Scientific Operations for Growth

Oct 18, 2022

Evozyne Names Senior Vice President of Research and Development

Sep 20, 2022

Evozyne Announces Multi-Target Research Collaboration and License Agreement with Takeda to Develop Next-Generation Gene Therapies

Apr 5, 2022

Evozyne Announces a Strategic Collaboration for Development of Novel Biopharmaceutical Therapeutics

Feb 1, 2021

Evozyne and Takeda Announce Strategic Collaboration and License Agreement

Jan 25, 2021

Synthetic Protein Design and Production Publication Confirms Evozyne’s Revolutionary Technology

Nov 3, 2020

Sterling Bay Signs Lease with Evozyne, LLC at Lincoln Park Life Science Building, 2430 N Halsted

Aug 6, 2020

University of Chicago Professor Cofounds Data-Driven Molecular Engineering Company

Jul 24, 2020